Cemex SAB de CV
NYSE:CX
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
5.17
9.15
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Cemex SAB de CV
Wall Street
Price Targets
CX Price Targets Summary
Cemex SAB de CV
According to Wall Street analysts, the average 1-year price target for
CX
is 5.9 USD
with a low forecast of 5.52 USD and a high forecast of 6.46 USD.
CX Last Price Targets
Cemex SAB de CV
The latest public price target was made on Oct 29, 2024 by
Francisco Suarez
from
Scotiabank
,
who expects
CX
stock to
rise by 58%
over the next 12 months.
You can read more about this price target by viewing
the article on StreetInsider.
| Analyst | Price Target | Date | Article |
|---|---|---|---|
Francisco Suarez
Scotiabank
|
8.9
USD
Upside 58% |
1 month ago
Oct 29, 2024
|
CEMEX (CX) PT Lowered to $8.90 at Scotiabank
StreetInsider
|
Anthony Codling
RBC Capital
|
6
USD
Upside 6% |
1 month ago
Oct 29, 2024
|
CEMEX (CX) PT Lowered to $6 at RBC Capital
StreetInsider
|
|
Anthony Codling
RBC Capital
|
6.5
USD
Upside 15% |
2 months ago
Oct 8, 2024
|
RBC Capital Upgrades CEMEX (CX) to Sector Perform
StreetInsider
|
Benjamin Theurer
Barclays
|
9
USD
Upside 59% |
4 months ago
Jul 31, 2024
|
Barclays Upgrades CEMEX (CX) to Overweight
StreetInsider
|
Bruno Amorim
Goldman Sachs
|
9
USD
Upside 59% |
1 year ago
May 4, 2023
|
Cemex Analyst Says Discipline Is Paying Off, As Q1 Results Surpass Predictions
Benzinga
|
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is CX's stock price target?
Price Target
5.9
USD
According to Wall Street analysts, the average 1-year price target for
CX
is 5.9 USD
with a low forecast of 5.52 USD and a high forecast of 6.46 USD.
What is Cemex SAB de CV's Revenue forecast?
Projected CAGR
1%
For the last 8 years the
compound annual growth rate for
Cemex SAB de CV's revenue is
7%.
The projected
CAGR
for the next 4 years is
1%.
What is Cemex SAB de CV's Operating Income forecast?
Projected CAGR
3%
For the last 8 years the
compound annual growth rate for
Cemex SAB de CV's operating income is
7%.
The projected
CAGR
for the next 4 years is
3%.
What is Cemex SAB de CV's Net Income forecast?
Projected CAGR
-13%
For the last 8 years the
compound annual growth rate for
Cemex SAB de CV's net income is
16%.
The projected
CAGR
for the next 3 years is
-13%.
You don't have any saved screeners yet
